 Phase 12 clinical study evaluating safety Phase 1 and preliminary efficacy Phase 2 of donor regulatory T cells for patients with steroid-refractory chronic graft versus host disease GVHD after allogeneic hematopoietic stem cell transplantation HSCT. 